Genetics Adviser
PrivateLast Round
Accelerator
Mar 6, 2025
Total Funding Raised
$1.1M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Genetics Adviser operates in Healthcare & Life Sciences and is based in Toronto. Its latest recorded funding round was an Accelerator round in March 2025.
Genetics Adviser is a healthcare technology company that provides a digital platform to guide patients through the genetic testing process, from pre-test education and counseling to the return of results.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Patient Engagement, Vertical SaaS, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genetics Adviser Comparables
Compare Genetics Adviser with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nest Genomics | 84% | |
| My Gene Counsel | 82% | |
| Igentify | 82% |
For institutional investors. Book with your work email.
Genetics Adviser Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Mar 6, 2025 | ||||
| Accelerator | Jun 19, 2024 | ||||
| Accelerator | Oct 17, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Genetics Adviser Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ontario Bioscience Innovation Organization | Accelerator |
| University of Toronto Early Stage Technology | Seed, Accelerator |
| Archangel Network of Funds | Seed |
| TIAP | Seed, Accelerator |
| FACIT | Seed, Accelerator |
| Centre for Aging and Brain Health Innovation | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Added Australasia Inc, a Biotechnology / Life Sciences company.
- Jun 17, 2026
Added Marinahospital, a healthcare SMB, as a customer.
For institutional investors. Book with your work email.
Genetics Adviser Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Genetics Adviser's valuation, stock price, and market status.
Is Genetics Adviser a public or private company?
Genetics Adviser is a private company.
What is the current stock price of Genetics Adviser?
Genetics Adviser is a private company, so its shares have no public market price. Caplight tracks Genetics Adviser's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Genetics Adviser worth (valuation)?
Valuation information for Genetics Adviser is not publicly available.
Can I buy Genetics Adviser stock?
Genetics Adviser shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Genetics Adviser's last funding round?
Genetics Adviser's most recent funding round was Accelerator on March 6, 2025.
Who are the main investors in Genetics Adviser?
Key investors in Genetics Adviser include FACIT.
Will Genetics Adviser IPO soon?
No public IPO plans have been announced for Genetics Adviser.
How can I track Genetics Adviser secondary market activity?
Caplight tracks bids, offers, and trades in Genetics Adviser's shares on secondary markets.